Biogen expands immunology pipeline with agreement to acquire raythera inc.

{
  "signal_id": "c909cd3d-cc8a-47ac-be4e-53a092f3bc76",
  "signal_type": "news",
  "signal_subtype": "acquires",
  "detected_at": "2026-06-17T00:00:00+00:00",
  "company": {
    "name": "Biogen",
    "domain": "biogen.com"
  },
  "data": {
    "url": "https://bcbn.org/boston-cambridge-biotech-news/2026/06/17/biogen-expands-immunology-pipeline-with-agreement-to-acquire-raythera-inc",
    "title": "Biogen expands immunology pipeline with agreement to acquire raythera inc.",
    "ticker": "NASDAQ:BIIB",
    "excerpt": "Biogen expands immunology pipeline with agreement to acquire raythera inc.\n\nJune 17, 2026 BCBN news, syndication comments off on Biogen expands immunology pipeline with agreement to acquire raythera inc.\n\nAcquisition adds multiple immunology assets to Biogen's portfolio, including a lead asset poised to enter Phase 1 development",
    "summary": "Biogen, Inc. acquires RayThera, Inc..",
    "planning": false,
    "image_url": "https://bcbn.org/wp-content/uploads/sites/2/2021/06/BCBN-logo-e1622668437580.png",
    "confidence": 0.6164,
    "published_at": "2026-06-17T00:00:00Z",
    "article_sentence": "June 17, 2026 BCBN news, syndication comments off on Biogen expands immunology pipeline with agreement to acquire raythera inc.",
    "related_company_name": "RayThera, Inc.",
    "related_company_domain": "raythera.com"
  }
}

curl https://signals.autobound.ai/v1/signals/c909cd3d-cc8a-47ac-be4e-53a092f3bc76 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"biogen.com","limit":20}'